Platelet plasminogen activator inhibitor 1 in patients with type II diabetes


Autoria(s): Jokl, R; Laimins, M; Klein, R L; Lyons, T J; Lopes-Virella, M F; Colwell, J A
Data(s)

01/08/1994

Resumo

To compare platelet plasminogen activator inhibitor 1 (PAI-1) concentration in type II diabetic patients and healthy control subjects.

Identificador

http://pure.qub.ac.uk/portal/en/publications/platelet-plasminogen-activator-inhibitor-1-in-patients-with-type-ii-diabetes(adf7502f-a549-4c2a-9b3c-bf770f647ce6).html

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Jokl , R , Laimins , M , Klein , R L , Lyons , T J , Lopes-Virella , M F & Colwell , J A 1994 , ' Platelet plasminogen activator inhibitor 1 in patients with type II diabetes ' Diabetes Care , vol 17 , no. 8 , pp. 818-23 .

Palavras-Chave #Blood Platelets #Blood Pressure #C-Peptide #Cholesterol #Diabetes Mellitus, Type 2 #Diabetic Diet #Female #Hemoglobin A, Glycosylated #Humans #Hypoglycemic Agents #Male #Middle Aged #Plasminogen Activator Inhibitor 1 #Platelet Aggregation #Platelet Factor 4 #Reference Values #Triglycerides #beta-Thromboglobulin
Tipo

article